ATE360034T1 - Antikörper gegen metastin und dessen verwendung zur diagnose von schwangerschaft - Google Patents
Antikörper gegen metastin und dessen verwendung zur diagnose von schwangerschaftInfo
- Publication number
- ATE360034T1 ATE360034T1 AT02765578T AT02765578T ATE360034T1 AT E360034 T1 ATE360034 T1 AT E360034T1 AT 02765578 T AT02765578 T AT 02765578T AT 02765578 T AT02765578 T AT 02765578T AT E360034 T1 ATE360034 T1 AT E360034T1
- Authority
- AT
- Austria
- Prior art keywords
- metastin
- derivative
- antibody
- antibodies
- specifically
- Prior art date
Links
- 102000013599 Kisspeptins Human genes 0.000 title abstract 4
- 108010012048 Kisspeptins Proteins 0.000 title abstract 4
- KAHDONZOCXSKII-NJVVDGNHSA-N kisspeptin Chemical compound C([C@@H](C(=O)N[C@@H](CO)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N1[C@@H](CCC1)C(=O)N[C@@H](C)C(=O)N1[C@@H](CCC1)C(=O)N[C@@H](CCC(N)=O)C(=O)NCC(=O)N[C@@H](C)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(O)=O)C(=O)N[C@@H](CC(C)C)C(=O)N1[C@@H](CCC1)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC=1C=CC(O)=CC=1)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC=1C2=CC=CC=C2NC=1)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CO)C(=O)N[C@@H](CC=1C=CC=CC=1)C(=O)NCC(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CC=1C=CC=CC=1)C(N)=O)NC(=O)[C@H]1N(CCC1)C(=O)[C@H](C)NC(=O)[C@H](CO)NC(=O)[C@H](CC(C)C)NC(=O)CNC(=O)[C@H]1N(CCC1)C(=O)[C@H](CCC(N)=O)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](CCCNC(N)=N)NC(=O)[C@H](CO)NC(=O)CNC(=O)[C@H](CO)NC(=O)[C@H](CO)NC(=O)[C@H](CCC(O)=O)NC(=O)[C@H]1N(CCC1)C(=O)[C@H]1N(CCC1)C(=O)[C@H]1N(CCC1)C(=O)[C@H](CO)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CO)NC(=O)[C@@H](NC(=O)CN)[C@@H](C)O)C1=CN=CN1 KAHDONZOCXSKII-NJVVDGNHSA-N 0.000 title abstract 4
- 230000035935 pregnancy Effects 0.000 title abstract 2
- 229940039227 diagnostic agent Drugs 0.000 abstract 2
- 239000000032 diagnostic agent Substances 0.000 abstract 2
- 108090000765 processed proteins & peptides Proteins 0.000 abstract 2
- 150000001413 amino acids Chemical group 0.000 abstract 1
- 229920001184 polypeptide Polymers 0.000 abstract 1
- 102000004196 processed proteins & peptides Human genes 0.000 abstract 1
- 230000035945 sensitivity Effects 0.000 abstract 1
Classifications
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
- G01N33/689—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids related to pregnancy or the gonads
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
- C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
- G01N33/6854—Immunoglobulins
- G01N33/6857—Antibody fragments
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2800/00—Detection or diagnosis of diseases
- G01N2800/36—Gynecology or obstetrics
- G01N2800/368—Pregnancy complicated by disease or abnormalities of pregnancy, e.g. preeclampsia, preterm labour
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP2001285853 | 2001-09-19 |
Publications (1)
Publication Number | Publication Date |
---|---|
ATE360034T1 true ATE360034T1 (de) | 2007-05-15 |
Family
ID=19108930
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
AT02765578T ATE360034T1 (de) | 2001-09-19 | 2002-09-18 | Antikörper gegen metastin und dessen verwendung zur diagnose von schwangerschaft |
Country Status (6)
Country | Link |
---|---|
US (2) | US7112662B2 (de) |
EP (1) | EP1428835B1 (de) |
AT (1) | ATE360034T1 (de) |
CA (1) | CA2460803A1 (de) |
DE (1) | DE60219645T2 (de) |
WO (1) | WO2003027149A1 (de) |
Families Citing this family (13)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP1577323B1 (de) | 2002-12-26 | 2013-07-10 | Takeda Pharmaceutical Company Limited | Metastinderivat und verwendung davon |
EP1583846B1 (de) * | 2003-01-17 | 2011-11-16 | The Chinese University Of Hong Kong | Zirkulierende mrna als diagnostische marker für erkankungen die mit einer schwangerschaft zusammenhängen |
US7754220B2 (en) * | 2003-03-12 | 2010-07-13 | Takeda Pharmaceutical Company Limited | Methods of inhibiting secretion of follicle-stimulating hormone and testosterone |
CN101845091A (zh) * | 2004-06-25 | 2010-09-29 | 武田药品工业株式会社 | 转移素衍生物及其用途 |
US20090099334A1 (en) * | 2005-12-22 | 2009-04-16 | Takeda Pharmaceutical Company Limited | Metastin derivatives and use thereof |
US8404643B2 (en) * | 2005-12-22 | 2013-03-26 | Takeda Pharmaceutical Company Limited | Metastin derivatives and use thereof |
TWI386417B (zh) * | 2005-12-22 | 2013-02-21 | Takeda Pharmaceutical | 轉移抑素衍生物及其用途 |
DE102006015001A1 (de) * | 2006-03-31 | 2007-10-11 | NMI Naturwissenschaftliches und Medizinisches Institut an der Universität Tübingen | Verfahren zum Nachweis und/oder zur Anreicherung von Analytproteinen und/oder Analytpeptiden aus einer komplexen Proteinmischung |
TWI404726B (zh) * | 2006-10-25 | 2013-08-11 | Takeda Pharmaceutical | 腫瘤轉移抑制素衍生物及其用途 |
HUE030900T2 (en) * | 2008-07-30 | 2017-06-28 | Takeda Pharmaceuticals Co | Metastin derivative and its use |
US20110171160A1 (en) * | 2008-09-19 | 2011-07-14 | Nektar Therapeutics | Polymer conjugates of kiss1 peptides |
WO2010033240A2 (en) | 2008-09-19 | 2010-03-25 | Nektar Therapeutics | Carbohydrate-based drug delivery polymers and conjugates thereof |
EP2783388A4 (de) * | 2011-11-23 | 2015-12-09 | Quest Diagnostics Invest Inc | Kisspeptin-54 nachweis durch tandem-massenspektrometrie |
Family Cites Families (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
FR2762601B3 (fr) * | 1997-04-29 | 1999-06-04 | Bio Merieux | Polypeptide capable de reagir avec les anticorps de patients atteints de sclerose en plaques et utilisations |
JP4486187B2 (ja) | 1998-10-27 | 2010-06-23 | 武田薬品工業株式会社 | 新規g蛋白質共役型レセプター蛋白質、そのdnaおよびそのリガンド |
CA2404257A1 (en) * | 2000-03-30 | 2001-10-11 | Takeda Chemical Industries, Ltd. | Novel protein, dna thereof and process for producing the same |
AU2001277986A1 (en) * | 2000-07-25 | 2002-02-05 | Axcell Biosciences Corporation | Identification and isolation of novel polypeptides having pdz domains and methods of using same |
-
2002
- 2002-09-18 WO PCT/JP2002/009557 patent/WO2003027149A1/ja active IP Right Grant
- 2002-09-18 AT AT02765578T patent/ATE360034T1/de not_active IP Right Cessation
- 2002-09-18 EP EP02765578A patent/EP1428835B1/de not_active Expired - Lifetime
- 2002-09-18 US US10/490,125 patent/US7112662B2/en not_active Expired - Fee Related
- 2002-09-18 CA CA002460803A patent/CA2460803A1/en not_active Abandoned
- 2002-09-18 DE DE60219645T patent/DE60219645T2/de not_active Expired - Lifetime
-
2006
- 2006-08-02 US US11/498,439 patent/US7691979B2/en not_active Expired - Fee Related
Also Published As
Publication number | Publication date |
---|---|
EP1428835B1 (de) | 2007-04-18 |
US20040236077A1 (en) | 2004-11-25 |
EP1428835A1 (de) | 2004-06-16 |
US7691979B2 (en) | 2010-04-06 |
DE60219645T2 (de) | 2007-08-09 |
EP1428835A4 (de) | 2005-09-28 |
WO2003027149A1 (fr) | 2003-04-03 |
CA2460803A1 (en) | 2003-04-03 |
US20060275286A1 (en) | 2006-12-07 |
US7112662B2 (en) | 2006-09-26 |
DE60219645D1 (de) | 2007-05-31 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
DK1571970T3 (da) | Diagnose og monitorering af sygdomme | |
ATE360034T1 (de) | Antikörper gegen metastin und dessen verwendung zur diagnose von schwangerschaft | |
BRPI0616712B8 (pt) | método para amidar polipeptídeos com terminais c de aminoácido básicos por meio de endoproteases específicas | |
WO2007127977A3 (en) | Methods of evaluating peptide mixtures | |
HK1089232A1 (en) | Use of a midregional proadrenomedullin partial peptide in biological fluids in the production of immological diagnostic agents | |
DE60322188D1 (de) | Zytokin (zcytor17-ligand) | |
MX337991B (es) | Metodo para detectar cancer. | |
ATE460430T1 (de) | Kit zur untersuchung von menschlichem niedermolekulargewicht cd14 und antikörper | |
DE602004001533D1 (de) | Immunotestverfahren für Herz-Troponin I | |
EP1708745A4 (de) | Antikörper für onkogene stämme von hpv und verfahren zu deren verwendung | |
ATE335763T1 (de) | Sandwich-immunoassay zur bestimmung von proanp- teilpeptiden | |
ATE438657T1 (de) | Charakterisierung von granulozytischer ehrlichia und methoden für ihre verwendung. | |
DK1336109T3 (da) | Kit og fremgangsmåde til at påvise proteinet EMS-1 | |
EP1560025A3 (de) | Marker spezifisch für Diabetes | |
BR9815788B1 (pt) | proteÍna quimÉrica. | |
Fischer et al. | Adrenomedullin disulfide bond mimetics uncover structural requirements for AM1 receptor activation | |
ATE371192T1 (de) | Diagnose von autismus | |
CA2597545A1 (en) | Antibody for assay of adamts13 activity and method for assaying the activity | |
US20110028409A1 (en) | Detection of anti-ribosomal p protein antibodies by means of synthetic peptides | |
WO2002102847A1 (fr) | Nouveau ligand et son adn | |
WO2002008245A3 (en) | Labeled peptides, proteins and antibodies and processes and intermediates useful for their preparation | |
WO2006089801A3 (de) | Verfahren zum redox-potential-abhängigen nachweis von targetmolekülen durch wechselwirkende polypeptide | |
SG156619A1 (en) | Novel cancer associated antibodies and antigens and their use in cancer diagnosis | |
TW200702337A (en) | Coronavirus S peptides | |
ATE511643T1 (de) | Fragment des neurosekretorischen proteins vgf als biomarker für morbus alzheimer |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
RER | Ceased as to paragraph 5 lit. 3 law introducing patent treaties |